This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Mucinous ovarian tumours

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

These account for 15-20% of ovarian tumours. They can attain a huge size, often filling the entire pelvis and abdomen. They are often multilocular and contain viscid mucin. These tumours may rupture and cause pseudomyxoma peritonei (see linked item).

Benign mucinous cystadenoma:

  • about 80% of mucinous ovarian tumours
  • 20-25% of all benign ovarian neoplasms
  • bilateral in 5-10% of cases
  • peak incidence between 30-50 years of age
  • 100% 10 year survival

Borderline mucinous cystadenoma:

  • about 10% of mucinous ovarian tumours
  • bilateral in 10% of cases
  • 60% 10 year survival

Malignant mucinous cystadenocarcinoma:

  • about 10% of mucinous ovarian tumours
  • uncommon - 5-10% of primary malignant ovarian neoplasms
  • bilateral in 15-30% of cases
  • peak incidence between 40-70 years of age
  • 34% 10 year survival

Reference

  1. Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.